Triple

T363283
Position Surface form Disambiguated ID Type / Status
Subject Genentech E7901 entity
Predicate notableProduct P1448 FINISHED
Object Herceptin
Herceptin is a targeted monoclonal antibody drug used primarily to treat HER2-positive breast cancer by blocking the HER2 receptor on cancer cells.
 E46088 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Herceptin | Statement: [Genentech, notableProduct, Herceptin]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Herceptin
Context triple: [Genentech, notableProduct, Herceptin]
  • A. Tysabri
    Tysabri is a monoclonal antibody medication primarily used to treat relapsing forms of multiple sclerosis and Crohn’s disease.
  • B. Pregny-Chambésy
    Pregny-Chambésy is a small, affluent municipality on the shores of Lake Geneva in the canton of Geneva, Switzerland, known for hosting several international organizations and diplomatic missions.
  • C. Genentech
    Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
  • D. Aduhelm
    Aduhelm is an Alzheimer’s disease drug developed by Biogen that targets amyloid-beta plaques in the brain.
  • E. Plegridy
    Plegridy is a pegylated interferon beta-1a medication used to treat relapsing forms of multiple sclerosis.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Herceptin
Triple: [Genentech, notableProduct, Herceptin]
Generated description
Herceptin is a targeted monoclonal antibody drug used primarily to treat HER2-positive breast cancer by blocking the HER2 receptor on cancer cells.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Herceptin
Target entity description: Herceptin is a targeted monoclonal antibody drug used primarily to treat HER2-positive breast cancer by blocking the HER2 receptor on cancer cells.
  • A. Tysabri
    Tysabri is a monoclonal antibody medication primarily used to treat relapsing forms of multiple sclerosis and Crohn’s disease.
  • B. Pregny-Chambésy
    Pregny-Chambésy is a small, affluent municipality on the shores of Lake Geneva in the canton of Geneva, Switzerland, known for hosting several international organizations and diplomatic missions.
  • C. Genentech
    Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
  • D. Aduhelm
    Aduhelm is an Alzheimer’s disease drug developed by Biogen that targets amyloid-beta plaques in the brain.
  • E. Plegridy
    Plegridy is a pegylated interferon beta-1a medication used to treat relapsing forms of multiple sclerosis.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a2e7e880008190a6ad7e06e5d03007 completed Feb. 28, 2026, 1:04 p.m.
NER Named-entity recognition batch_69a2ebd1016481909b8ba3b047a47145 completed Feb. 28, 2026, 1:21 p.m.
NED1 Entity disambiguation (via context triple) batch_69a3e86533a481909bab5f0b52114c6a completed March 1, 2026, 7:19 a.m.
NEDg Description generation batch_69a3e99fd210819099e83cd183a4daa7 completed March 1, 2026, 7:24 a.m.
NED2 Entity disambiguation (via description) batch_69a3ea45c86c8190a6c215430601ad15 completed March 1, 2026, 7:27 a.m.
Created at: Feb. 28, 2026, 1:08 p.m.